Researchers have discovered and validated a blood test that can predict with greater than 90 percent accuracy if a healthy person will develop mild cognitive impairment or Alzheimer’s disease within three years.
Described in the April issue of Nature Medicine, the study heralds the potential for developing treatment strategies for Alzheimer’s at an earlier stage, when therapy would be more effective at slowing or preventing onset of symptoms. It is the first known published report of blood-based biomarkers for preclinical Alzheimer’s.
The test identifies 10 lipids, or fats, in the blood that predict disease onset. It could be ready for use in clinical studies in as few as two years and, researchers say, other diagnostic uses are possible.
“Our novel blood test offers the potential to identify people at risk for progressive cognitive decline and can change how patients, their families and treating physicians plan for and manage the disorder,” says the study’s corresponding author Howard J. Federoff, MD, PhD, professor of neurology and executive vice president for health sciences at Georgetown University Medical Center.
There is no cure or effective treatment for Alzheimer’s. Worldwide, about 35.6 million individuals have the disease and, according to the World Health Organization, the number will double every 20 years to 115.4 million people with Alzheimer’s by 2050.
Federoff explains there have been many efforts to develop drugs to slow or reverse the progression of Alzheimer’s disease, but all of them have failed. He says one reason may be the drugs were evaluated too late in the disease process.
“The preclinical state of the disease offers a window of opportunity for timely disease-modifying intervention,” Federoff says. “Biomarkers such as ours that define this asymptomatic period are critical for successful development and application of these therapeutics.”
The Latest on: Alzheimer’s
via Google News
The Latest on: Alzheimer’s
- People with Alzheimer's Have Special Needs with COVID-19on March 24, 2020 at 12:37 pm
One of your neighbors posted in Neighbor Posts. Click through to read what they have to say. (The views expressed in this post are the author’s own.) ...
- Medical Care Corporation Achieves Phase I Milestone in Study to Detect Pre-Symptomatic Alzheimer's Diseaseon March 24, 2020 at 10:15 am
Medical Care Corporation (MCC) today announced the achievement of its Phase I milestone in a study of the corporation's digital cognitive biomarkers for detecting Alzheimer's disease in cognitively ...
- Inflamed Brains in FTD; Alzheimer’s and Apnea; How COVID-19 Is Disrupting Neurologyon March 24, 2020 at 8:37 am
(Neurology Today) The virus also is changing clinical trials: to keep elderly participants safe, Axsome Therapeutics expedited completion of its phase II/III trial of a drug to treat ...
- Alzheimer's Sufferer in Spain Smiles Believing Ovation for Health Workers Fighting Coronavirus Is for His Harmonica Playingon March 24, 2020 at 8:18 am
The man's caregiver has told him that people are clapping from their windows due to his musical performance.
- Researchers identify novel blood-based markers to detect Alzheimer’s diseaseon March 24, 2020 at 6:11 am
In a recent study published in the Journal of Alzheimer’s Disease, researchers at Okayama University developed a technique to uncover molecules within the blood which can help doctors differentiate ...
- Okayama University Research: Novel Blood-based Markers to Detect Alzheimer's Diseaseon March 23, 2020 at 11:50 pm
OKAYAMA, Japan, March 24, 2020 /PRNewswire/ -- In a recent study published in the Journal of Alzheimer's Disease, researchers at Okayama University developed a technique to uncover molecules within ...
- Alzheimer's Therapeutics Market: Global Industry Opportunities, Size, Share, Industry Outlook and Strategies 2022on March 23, 2020 at 10:34 pm
The latest market report published by Credence Research, Inc. "Global Alzheimer's Therapeutics Market - Growth, Share, Opportunities, Pipeline Analysis, Competitive Analysis, and Forecast, 2016 - 2022 ...
- 'Dueling Banjos' Eric Weissberg Dies at 80 After Battle with Alzheimer's Diseaseon March 23, 2020 at 7:03 pm
Sending our condolences ...
- Author Correction: Classification and Visualization of Alzheimer’s Disease using Volumetric Convolutional Neural Network and Transfer Learningon March 23, 2020 at 4:22 pm
Hayit, G., Bram van, G. & Ronald, M. S. Guest Editorial Deep Learning in Medical Imaging: Overview and Future Promise of an Exciting New Technique. IEEE Transactions on Medical Imaging. 35, 1153–1159 ...
- Yep, Exercise Can Increase Brain Function—And May Help Reduce a Marker of Alzheimer’son March 23, 2020 at 10:00 am
Recent research published in Brain Plasticity found that aerobic exercise may help lower your risk of developing Alzheimer’s disease. After going through 26 weeks of training, people who improved ...
via Bing News